Abiopharma

🔍 WHISLER J STEVEN (Executive)

Company: CSX CORP (CSX)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 791 shares of Common Stock at $47.39 per share (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: false | shares_owned_after: 97,326.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | shares_owned_after: 126,354.00

Footnotes:

• F1: Exempt payment of director's fees and/or annual retainer in the form of CSX Common Stock pursuant to the 2019 CSX Stock and Incentive Award Plan.
• F2: Includes 606 shares acquired through the reinvestment of dividends since March 13, 2026, the date of the last reportable transaction.
• F3: By Trustee, CSX Directors Deferred Compensation Plan (the "Plan"). The shares are payable after the reporting person ceases to be a director or otherwise pursuant to the applicable deferral election under the Plan.